Factors associated with the progression of aortic valve calcification in older adults. (15th June 2023)
- Record Type:
- Journal Article
- Title:
- Factors associated with the progression of aortic valve calcification in older adults. (15th June 2023)
- Main Title:
- Factors associated with the progression of aortic valve calcification in older adults
- Authors:
- Leibowitz, David
Yoshida, Yuriko
Jin, Zhezhen
Nakanishi, Koki
Mannina, Carlo
Elkind, Mitchell S.V.
Rundek, Tatjana
Homma, Shunichi
Sacco, Ralph L.
Di Tullio, Marco R. - Abstract:
- Abstract: Background: Aortic valve calcification (AVC) is a common valvular abnormality that predisposes to stenosis; AVC progression and factors associated with it remain unclear. We investigated the association of clinical factors and serum biomarkers with AVC progression in a population-based cohort of older adults. Methods: Participants enrolled in both the Cardiovascular Abnormalities and Brain Lesion study (CABL; years 2005–2010) and the Subclinical Atrial Fibrillation And Risk of Ischemic Stroke study (SAFARIS;2014–2019) represent the study cohort. AVC was defined as bright dense echoes >1 mm in size on ≥1 cusps; each cusp was graded on a scale of 0 (normal) to 3 (severe calcification) at baseline and follow up. Serum biomarkers were measured at the time of follow-up assessment. Results: 373 participants (mean 68.1 ± 7.6 years of age, 146 M/ 227F) were included. 139 (37%) had AVC progression;93 (25%) had mild progression (1 grade), and 46 (12%) had moderate-severe progression (≥2 grades). The only significant clinical predictor of any progression was the use of anti-hypertensive medication which was associated with older age, higher BMI and more frequent hypertension, diabetes and hyperlipidemia. In multivariable analysis including biomarkers, transforming growth factor beta 1 (TGF-β1) was significantly associated with both all and moderate-severe AVC progression. Conclusions: A significant number of elderly subjects with AVC show progression of their valve disease;Abstract: Background: Aortic valve calcification (AVC) is a common valvular abnormality that predisposes to stenosis; AVC progression and factors associated with it remain unclear. We investigated the association of clinical factors and serum biomarkers with AVC progression in a population-based cohort of older adults. Methods: Participants enrolled in both the Cardiovascular Abnormalities and Brain Lesion study (CABL; years 2005–2010) and the Subclinical Atrial Fibrillation And Risk of Ischemic Stroke study (SAFARIS;2014–2019) represent the study cohort. AVC was defined as bright dense echoes >1 mm in size on ≥1 cusps; each cusp was graded on a scale of 0 (normal) to 3 (severe calcification) at baseline and follow up. Serum biomarkers were measured at the time of follow-up assessment. Results: 373 participants (mean 68.1 ± 7.6 years of age, 146 M/ 227F) were included. 139 (37%) had AVC progression;93 (25%) had mild progression (1 grade), and 46 (12%) had moderate-severe progression (≥2 grades). The only significant clinical predictor of any progression was the use of anti-hypertensive medication which was associated with older age, higher BMI and more frequent hypertension, diabetes and hyperlipidemia. In multivariable analysis including biomarkers, transforming growth factor beta 1 (TGF-β1) was significantly associated with both all and moderate-severe AVC progression. Conclusions: A significant number of elderly subjects with AVC show progression of their valve disease; individual vascular risk factors are not associated with AVC progression, although a combined effect may exist. Higher levels of TGF-β1 are observed in individuals with AVC progression. Graphical abstract: Unlabelled Image Highlights: Aortic valve calcification (AVC) is a common progressive valvular abnormality. We measured AVC in elderly subjects at baseline and after a mean 8 year follow up. Individual vascular risk factors are not associated with AVC progression. Higher levels of transforming growth factor beta in subjects with AVC progression. … (more)
- Is Part Of:
- International journal of cardiology. Volume 381(2023)
- Journal:
- International journal of cardiology
- Issue:
- Volume 381(2023)
- Issue Display:
- Volume 381, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 381
- Issue:
- 2023
- Issue Sort Value:
- 2023-0381-2023-0000
- Page Start:
- 76
- Page End:
- 80
- Publication Date:
- 2023-06-15
- Subjects:
- Aortic valve calcification -- Echocardiography -- Transforming growth factor β1
Cardiology -- Periodicals
Electronic journals
616.12 - Journal URLs:
- http://www.clinicalkey.com/dura/browse/journalIssue/01675273 ↗
http://www.sciencedirect.com/science/journal/01675273 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijcard.2023.03.059 ↗
- Languages:
- English
- ISSNs:
- 0167-5273
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.158000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 27056.xml